No more needles? new device aims to make blood tests painless
NCT ID NCT07260799
First seen Jun 24, 2026 · Last updated Jun 24, 2026
Summary
This study tests whether a new device called Tasso+, which collects blood from the skin (like a finger prick), can give the same results as a standard needle draw from a vein. Researchers will compare blood samples from 150 healthy adults and patients with abnormal lab values. If the device works well, it could make blood collection easier and less painful.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SERUM ANALYTES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Celesta / American Research Labs
RECRUITINGAtlantis, Florida, 33462, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Tasso+ Serum Gel Capillary Blood Collection System (a device for collecting blood from the skin)
What this could lead to
If successful, this could offer a less painful, more convenient way to collect blood for common lab tests, potentially making testing easier for patients.
What could go wrong
This is a small, early-stage study (150 people) comparing capillary to venous blood. It may not prove the device works for all patients or all tests, and results may not apply to other settings.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.